Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) FCF Margin (2022 - 2024)

Adial Pharmaceuticals' FCF Margin history spans 3 years, with the latest figure at 214815300.0% for Q2 2024.

  • For Q2 2024, FCF Margin rose 21481089529.0% year-over-year to 214815300.0%; the TTM value through Dec 2024 reached 4204.08%, down 3378732.0%, while the annual FY2021 figure was 25839.97%, 27948647.0% up from the prior year.
  • FCF Margin for Q2 2024 was 214815300.0% at Adial Pharmaceuticals, up from 987.64% in the prior quarter.
  • Across five years, FCF Margin topped out at 214815300.0% in Q2 2024 and bottomed at 48812.38% in Q1 2022.
  • The 3-year median for FCF Margin is 987.64% (2024), against an average of 42951915.44%.
  • The largest YoY upside for FCF Margin was 2000000000bps in 2024 against a maximum downside of 933986bps in 2024.
  • A 3-year view of FCF Margin shows it stood at 48812.38% in 2022, then skyrocketed by 109bps to 4404.71% in 2023, then skyrocketed by 4876840bps to 214815300.0% in 2024.
  • Per Business Quant, the three most recent readings for ADIL's FCF Margin are 214815300.0% (Q2 2024), 987.64% (Q1 2024), and 4404.71% (Q2 2023).